ID: ALA3262763

Max Phase: Preclinical

Molecular Formula: C34H45N5O6

Molecular Weight: 619.76

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N1CCN(C(=O)NC(CC(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]2(C)CO2)c2ccccc2)CC1

Standard InChI:  InChI=1S/C34H45N5O6/c1-23(2)19-28(31(42)34(4)22-45-34)36-32(43)29(20-25-11-7-5-8-12-25)35-30(41)21-27(26-13-9-6-10-14-26)37-33(44)39-17-15-38(16-18-39)24(3)40/h5-14,23,27-29H,15-22H2,1-4H3,(H,35,41)(H,36,43)(H,37,44)/t27?,28-,29-,34+/m0/s1

Standard InChI Key:  PYMIDORDAIMDSO-VDBHTJGKSA-N

Associated Targets(Human)

26S proteasome 143 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 619.76Molecular Weight (Monoisotopic): 619.3370AlogP: 2.61#Rotatable Bonds: 13
Polar Surface Area: 140.45Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.37CX Basic pKa: CX LogP: 2.35CX LogD: 2.35
Aromatic Rings: 2Heavy Atoms: 45QED Weighted: 0.29Np Likeness Score: -0.24

References

1. Zhang J, Cao J, Xu L, Zhou Y, Liu T, Li J, Hu Y..  (2014)  Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors.,  22  (11): [PMID:24767818] [10.1016/j.bmc.2014.04.011]

Source